172 related articles for article (PubMed ID: 9440739)
1. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.
Hesdorffer C; Ayello J; Ward M; Kaubisch A; Vahdat L; Balmaceda C; Garrett T; Fetell M; Reiss R; Bank A; Antman K
J Clin Oncol; 1998 Jan; 16(1):165-72. PubMed ID: 9440739
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
[TBL] [Abstract][Full Text] [Related]
3. Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
O'Shaughnessy JA; Cowan KH; Nienhuis AW; McDonagh KT; Sorrentino BP; Dunbar CE; Chiang Y; Wilson W; Goldspiel B; Kohler D
Hum Gene Ther; 1994 Jul; 5(7):891-911. PubMed ID: 7526902
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.
Takahashi S; Aiba K; Ito Y; Hatake K; Nakane M; Kobayashi T; Minowa S; Shibata H; Mitsuhashi J; Tsukahara S; Ishikawa E; Suzuki R; Tsuruo T; Sugimoto Y
Cancer Sci; 2007 Oct; 98(10):1609-16. PubMed ID: 17683514
[TBL] [Abstract][Full Text] [Related]
5. Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123.
Fruehauf S; Breems DA; Knaän-Shanzer S; Brouwer KB; Haas R; Löwenberg B; Nooter K; Ploemacher RE; Valerio D; Boesen JJ
Hum Gene Ther; 1996 Jun; 7(10):1219-31. PubMed ID: 8793546
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of gene-marked hematopoietic progenitors in myeloma patients after transplant of autologous long-term marrow cultures.
Stewart AK; Sutherland DR; Nanji S; Zhao Y; Lutzko C; Nayar R; Peck B; Ruedy C; McGarrity G; Tisdale J; Dubé ID
Hum Gene Ther; 1999 Aug; 10(12):1953-64. PubMed ID: 10466629
[TBL] [Abstract][Full Text] [Related]
7. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91.
Sugimoto Y; Tsukahara S; Sato S; Suzuki M; Nunoi H; Malech HL; Gottesman MM; Tsuruo T
J Gene Med; 2003 May; 5(5):366-76. PubMed ID: 12731085
[TBL] [Abstract][Full Text] [Related]
8. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Hum Cell; 1999 Sep; 12(3):115-23. PubMed ID: 10695018
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus that contains the MDR-1 chemotherapy resistance gene.
Hanania EG; Fu S; Zu Z; Hegewisch-Becker S; Korbling M; Hester J; Durett A; Andreeff M; Mechetner E; Holzmayer T
Gene Ther; 1995 Jun; 2(4):285-94. PubMed ID: 7552989
[TBL] [Abstract][Full Text] [Related]
10. Retroviral transfer and expression of the human multiple drug resistance (MDR) gene in peripheral blood progenitor cells.
Ward M; Pioli P; Ayello J; Reiss R; Urzi G; Richardson C; Hesdorffer C; Bank A
Clin Cancer Res; 1996 May; 2(5):873-6. PubMed ID: 9816243
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of multidrug resistance (MDR-1) gene transfer in patients undergoing high-dose therapy and peripheral blood stem cell transplantation for lymphoma.
Devereux S; Corney C; Macdonald C; Watts M; Sullivan A; Goldstone AH; Ward M; Bank A; Linch DC
Gene Ther; 1998 Mar; 5(3):403-8. PubMed ID: 9614561
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Rahman Z; Kavanagh J; Champlin R; Giles R; Hanania E; Fu S; Zu Z; Mehra R; Holmes F; Kudelka A; Claxton D; Verschraegen C; Gajewski J; Andreeff M; Heimfeld S; Berenson R; Ellerson D; Calvert L; Mechetner E; Holzmayer T; Dayne A; Hamer J; Bachier C; Ostrove J; Deisseroth A
Clin Cancer Res; 1998 Nov; 4(11):2717-21. PubMed ID: 9829734
[TBL] [Abstract][Full Text] [Related]
13. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy.
Guo C; Jin X
Cancer Invest; 2006 Nov; 24(7):659-68. PubMed ID: 17118775
[TBL] [Abstract][Full Text] [Related]
14. Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
Hanania EG; Giles RE; Kavanagh J; Fu SQ; Ellerson D; Zu Z; Wang T; Su Y; Kudelka A; Rahman Z; Holmes F; Hortobagyi G; Claxton D; Bachier C; Thall P; Cheng S; Hester J; Ostrove JM; Bird RE; Chang A; Korbling M; Seong D; Cote R; Holzmayer T; Deisseroth AB
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15346-51. PubMed ID: 8986814
[TBL] [Abstract][Full Text] [Related]
15. Results of retroviral and adenoviral approaches to cancer gene therapy.
Yin LH; Fu SQ; Nanakorn T; Garcia-Sanchez F; Chung I; Cote R; Pizzorno G; Hanania E; Heimfeld S; Crystal R; Deisseroth A
Stem Cells; 1998; 16 Suppl 1():247-50. PubMed ID: 11012168
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy using anticancer drug-resistance genes].
Sugimoto Y
Gan To Kagaku Ryoho; 1999 Jan; 26(1):1-9. PubMed ID: 9987494
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of a multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice.
Sugimoto Y; Sato S; Tsukahara S; Suzuki M; Okochi E; Gottesman MM; Pastan I; Tsuruo T
Cancer Gene Ther; 1997; 4(1):51-8. PubMed ID: 9012451
[TBL] [Abstract][Full Text] [Related]
18. Transient detection of beta-galactosidase activity in hematopoietic cells, following reinjection of retrovirally marked autologous blood progenitors in patients with breast or ovarian cancer receiving high-dose chemotherapy.
Bagnis C; Chabannon C; Gravis G; Imbert AM; Maroc C; Bardin F; Ladaique P; Viret F; Genre D; Faucher C; Stoppa AM; Vey N; Blaise D; Maraninchi D; Viens P; Mannoni P
Exp Hematol; 2002 Feb; 30(2):108-15. PubMed ID: 11823045
[TBL] [Abstract][Full Text] [Related]
19. Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs.
Omori F; Juopperi T; Chan CK; Chang YN; Phipps S; Nanji S; Zhao Y; Stewart AK; Dubé ID
J Hematother Stem Cell Res; 1999 Oct; 8(5):503-14. PubMed ID: 10791901
[TBL] [Abstract][Full Text] [Related]
20. Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo.
Emmons RV; Doren S; Zujewski J; Cottler-Fox M; Carter CS; Hines K; O'Shaughnessy JA; Leitman SF; Greenblatt JJ; Cowan K; Dunbar CE
Blood; 1997 Jun; 89(11):4040-6. PubMed ID: 9166843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
